RV, a deep learning model that estimates right ventricular size and function from echocardiograms, and assesses how those ...
As Chief Commercial Officer, Gould is responsible for commercial strategy, reimbursement and market access, and building ...
Price target updates for iRhythm Holdings now reflect a slightly lower fair value of US$171.33 compared with the prior US$178 ...
CABG patients who chose home-based telerehabilitation completed more objectively verified exercise sessions than those in ...
Apple has unveiled a new sensor system for its smartwatch, the Series 12 and Ultra 4. During the day, it measures heart rate ...
Community first responder activation did not improve 30-day survival in patients with out-of-hospital cardiac arrest, ...
Ultrahuman is introducing a heart scan feature for its users that will be rolling out to owners of the Ring Air and Ring Pro ...
Rhythm just closed a $287.5M deal for San Jose's VitalConnect, merging two Bay Area cardiac monitoring players.
Rhythm completes its VitalConnect acquisition, expanding cardiac monitoring across ambulatory, inpatient and hospital-to-home ...
Combination broadens iRhythm’s cardiac monitoring portfolio, advances its multi-vitals strategy and expands iRhythm’s addressable market across the continuum of care. iRhythm’s commercial scale, ...
Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results